Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Seminars in Cancer Biology|April 25, 2021
Precision medicine in myeloid malignanciesJörg Westermann, Lars BullingerMethods in Molecular Biology (Clifton, N.J.)|June 15, 2015
Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor ModelTam Nguyen-Hoai, Antonio Pezzutto, Jörg WestermannMethods in Molecular Biology (Clifton, N.J.)|June 22, 2022
Gene Gun Her2/neu DNA Vaccination: Evaluation of Vaccine Efficacy in a Syngeneic Her2/neu Mouse Tumor ModelTam Nguyen-Hoai, Oliver Hohn, Antonio Pezzutto, et al.Annals of Hematology|June 15, 2016
BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular featuresNina Rosa Neuendorff, Thomas Burmeister, Bernd Dörken, et al.Plos One|May 26, 2018
Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromesBenjamin N Ostendorf, Eva Flenner, Anne Flörcken, et al.Journal of Medical Case Reports|August 16, 2008
Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case reportIsrid Sturm, Joachim Oertel, Stephan Oertel, et al.Radiologie (Heidelberg, Germany)|February 6, 2026
[Imaging-based response criteria in oncology : Assessment of response to treatment in solid tumors and lymphomas]Lynn Jeanette Savic, Jörg Westermann, Annika Kurreck, et al.International Journal of Hematology|October 7, 2005
CD52 is not a promising immunotherapy target for most patients with multiple myelomaJörg Westermann, Georg Maschmeyer, Antje van Lessen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 2, 2009
Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcomeJörg Westermann, Ann-Christine Hecker, Anne Flörcken, et al.British Journal of Haematology|April 3, 2004
T cell recognition of bcr/abl in healthy donors and in patients with chronic myeloid leukaemiaJörg Westermann, Claudia Schlimper, Günther Richter, et al.Pageof 7